Medication info

Pregabalin 75 mg Capsule

Prescription medicationHard capsuleOralExpired
Ingredient · strength
Pregabalin›75mg / 1 capsule
Manufacturer / importer
Medix Pharmaceutical Co., Ltd.
Appearance
Hard capsules with a brownish-red upper and white lower part, filled with a white to pale yellow powder.
Packaging
30 capsules/bottle
Approval status
Expired

MFDS item code 201901243 · Approved 2019.02.26

This product's status changed to Expired on 2024.02.26. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of neuropathic pain and fibromyalgia; adjunctive treatment of partial-onset seizures
Who takes it
Adults
Adult dose
Administer the total daily dose of this medicine, pregabalin, orally in 2 divided doses, with or without food. Since this medicine is mainly excreted by the kidneys, the dose should be adjusted in patients with impaired renal function. (See section ‘5. Patients with renal impairment’.) 1. Neuropathic pain 1) Peripheral neuropathic pain Adults: The initial dose of this medicine may be 150 mg per day. Based on the response and tolerability of each patient, the dose may be increased to 300 mg per day after 3 to 7 days. If necessary, the dose may subsequently be increased to a maximum of 600 mg per day at 7-day intervals. 2) Central neuropathic pain Adults: The initial dose of this medicine may be 150 mg per day. Based on the response and tolerability of each patient, the dose may be increased to 300 mg per day after 1 week. After an additional 1 week, the dose may be increased to the target daily dose of 600 mg. If the target daily dose is not tolerated, dose reduction may be considered. (See section ‘4. Discontinuation’.) 2. Epilepsy Adults: The initial dose of this medicine may be 150 mg per day. Based on the response and tolerability of each patient, the dose may be increased to 300 mg per day after 1 week. If necessary, the dose may subsequently be increased to a maximum of 600 mg per day at 7-day intervals. 3. Fibromyalgia The recommended dose of this medicine for fibromyalgia is 300 mg ~ 450 mg per day. The initial dose is 75 mg twice daily (150 mg per day), and based on efficacy and tolerability, it may be increased to 150 mg twice daily (300 mg per day) within 1 week. For patients who do not experience sufficient benefit at a dose of 300 mg per day, the dose may be increased to 225 mg twice daily (450 mg per day) within 1 week. Clinical studies were also conducted at a dose of 600 mg per day, but there is no evidence of additional benefit or adequate tolerability at this dose. Considering the dose-dependent adverse reactions, doses exceeding 450 mg per day are not recommended. 4. Discontinuation Based on current clinical experience, if treatment with this medicine is discontinued, it should be withdrawn gradually over a period of at least 1 week. 5. Patients with renal impairment After entering the systemic circulation, this medicine is mainly excreted by the kidneys as unchanged drug. Since clearance of this medicine is directly affected by creatinine clearance, dose reduction in patients with impaired renal function should be individualized based on creatinine clearance. Creatinine clearance [Table 1] is determined using the following formula. *: For women, multiply the result obtained from the above calculation by 0.85. This medicine is effectively removed from plasma by hemodialysis (approximately 50% within 4 hours). In patients undergoing hemodialysis, the daily dose of pregabalin should be adjusted based on renal function. In addition to the daily dose based on renal function, an additional supplemental dose should be administered immediately after each 4-hour hemodialysis session. [Table 1]. Pregabalin dosage based on renal function

Ingredients

Manufacturer
Medix Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of neuropathic pain and fibromyalgia; adjunctive treatment of partial-onset seizures

  • Peripheral neuropathic pain
  • central neuropathic pain
  • partial seizures
  • fibromyalgia.
View approved original text

This medication is used for the treatment of peripheral and central neuropathic pain in adults. It is also effective as an adjunctive treatment for partial seizures in patients with epilepsy. Additionally, it helps relieve the symptoms of fibromyalgia. Therefore, it is utilized for the treatment of neuralgia, seizure episodes, and chronic musculoskeletal disorders.

How to take

Adult dose

Administer the total daily dose of this medicine, pregabalin, orally in 2 divided doses, with or without food. Since this medicine is mainly excreted by the kidneys, the dose should be adjusted in patients with impaired renal function. (See section ‘5. Patients with renal impairment’.) 1. Neuropathic pain 1) Peripheral neuropathic pain Adults: The initial dose of this medicine may be 150 mg per day. Based on the response and tolerability of each patient, the dose may be increased to 300 mg per day after 3 to 7 days. If necessary, the dose may subsequently be increased to a maximum of 600 mg per day at 7-day intervals. 2) Central neuropathic pain Adults: The initial dose of this medicine may be 150 mg per day. Based on the response and tolerability of each patient, the dose may be increased to 300 mg per day after 1 week. After an additional 1 week, the dose may be increased to the target daily dose of 600 mg. If the target daily dose is not tolerated, dose reduction may be considered. (See section ‘4. Discontinuation’.) 2. Epilepsy Adults: The initial dose of this medicine may be 150 mg per day. Based on the response and tolerability of each patient, the dose may be increased to 300 mg per day after 1 week. If necessary, the dose may subsequently be increased to a maximum of 600 mg per day at 7-day intervals. 3. Fibromyalgia The recommended dose of this medicine for fibromyalgia is 300 mg ~ 450 mg per day. The initial dose is 75 mg twice daily (150 mg per day), and based on efficacy and tolerability, it may be increased to 150 mg twice daily (300 mg per day) within 1 week. For patients who do not experience sufficient benefit at a dose of 300 mg per day, the dose may be increased to 225 mg twice daily (450 mg per day) within 1 week. Clinical studies were also conducted at a dose of 600 mg per day, but there is no evidence of additional benefit or adequate tolerability at this dose. Considering the dose-dependent adverse reactions, doses exceeding 450 mg per day are not recommended. 4. Discontinuation Based on current clinical experience, if treatment with this medicine is discontinued, it should be withdrawn gradually over a period of at least 1 week. 5. Patients with renal impairment After entering the systemic circulation, this medicine is mainly excreted by the kidneys as unchanged drug. Since clearance of this medicine is directly affected by creatinine clearance, dose reduction in patients with impaired renal function should be individualized based on creatinine clearance. Creatinine clearance [Table 1] is determined using the following formula. *: For women, multiply the result obtained from the above calculation by 0.85. This medicine is effectively removed from plasma by hemodialysis (approximately 50% within 4 hours). In patients undergoing hemodialysis, the daily dose of pregabalin should be adjusted based on renal function. In addition to the daily dose based on renal function, an additional supplemental dose should be administered immediately after each 4-hour hemodialysis session. [Table 1]. Pregabalin dosage based on renal function

Precautions

This drug is an anticonvulsant medication and may increase the risk of suicidal thoughts or behavior, so patients and caregivers should closely monitor for symptoms of depression, mood changes, or abnormal behavior. Patients with hypersensitivity to this medication or genetic conditions such as lactose intolerance should not take it. Diabetic patients may require adjustments to their blood sugar control medications due to weight gain, and if any symptoms of angioedema occur, the medication should be discontinued immediately. Elderly patients may experience side effects such as dizziness, drowsiness, or mental confusion, so caution is particularly necessary at the beginning of treatment. This drug can cause visual disturbances or changes in vision, so any unusual symptoms should be discussed with healthcare professionals. Withdrawal symptoms such as insomnia, headache, and anxiety can occur if the medication is stopped abruptly, so sudden discontinuation should be avoided, and caution is needed due to the potential for drug misuse and dependence. Patients with heart disease or renal impairment require special caution when taking this drug, and the risk of respiratory depression may increase when used concurrently with other central nervous system depressants. Pregnant women should avoid this medication in early pregnancy as it may affect the fetus, and women of childbearing potential should use effective contraception. Lactating women should consult healthcare professionals regarding breastfeeding or discontinuing this medication, as it may pass into breast milk. Caution is advised when driving or operating machinery due to the risk of dizziness and drowsiness leading to accidents. In case of overdose, symptoms such as confusion, drowsiness, and seizures may occur, necessitating immediate medical attention. This medication should be kept out of reach of children and should not be transferred to other containers. If severe allergic reactions such as skin rash, difficulty breathing, or facial swelling occur, the medication should be stopped immediately and a healthcare professional informed.

Side effects

Suicidal thoughts, suicidal behavior, depression, abnormal changes in mood and behavior, angioedema, facial swelling, perioral swelling, upper airway swelling, dizziness, drowsiness, loss of consciousness, confusion, mental disorders, blurred vision, changes in vision, insomnia, headache, nausea, anxiety, diarrhea, influenza-like illness, restlessness, depression, pain, sweating, misuse, abuse, dependence, congestive heart failure, severe respiratory depression, rhinitis, neutropenia, increased appetite, loss of appetite, hypoglycemia, confusion, disorientation, irritability, depression, euphoria, difficulty in finding appropriate terms, hallucinations, abnormal dreams, increased libido, panic attacks, loss of impulse control, apathy, dizziness, drowsiness, ataxia, motor coordination issues, balance disorders, amnesia, attention deficit, memory impairment, tremors, dysarthria, sensory abnormalities, sensory loss, sedation, hypersomnia, cognitive impairment, nystagmus, speech disorders, fascicular myokymia, reduced reflexes, movement disorders, psychomotor agitation, positional dizziness, perceptual hypersensitivity, burning sensation, activity tremor, syncope, stupor, hypokinesia, olfactory disturbances, taste loss, writing difficulties, blurred vision, diplopia, loss of peripheral vision, visual disturbances, visual field deficits, photopsia, dry eyes, ocular edema, reduced vision, eye pain, eye fatigue, increased tear production, ocular irritation, mydriasis, variability in depth perception during vibration, strabismus, brightness perception changes, vertigo, hyperacusis, first-degree heart block, tachycardia, sinus bradycardia, sinus tachycardia, sinus arrhythmia, hypotension, hypertension, flushing, facial flushing, peripheral coldness, dyspnea, epistaxis, cough, nasal congestion, rhinitis, snoring, throat tightness, nasal dryness, respiratory depression, vomiting, abdominal distension, constipation, dry mouth, bloating, excessive salivation, gastroesophageal reflux disease, oral sensation loss, ascites, dysphagia, pancreatitis, sweating, papular rash, hives, cold sweats, muscle cramps, joint pain, back pain, limb pain, cervical spasms, joint swelling, myalgia, muscle spasms, neck pain, muscle stiffness, rhabdomyolysis, urinary disorders, urinary incontinence, decreased urination, renal failure, erectile dysfunction, delayed ejaculation, sexual dysfunction, dysmenorrhea, amenorrhea, mastalgia, nipple discharge, gynecomastia, peripheral edema, edema, gait abnormalities, falls, feeling drunk, sensory abnormalities, fatigue, chest tightness, generalized edema, pain, fever, chills, weakness, thirst, weight gain, increased alanine aminotransferase, elevated blood creatine phosphokinase, increased aspartate aminotransferase, increased blood glucose, decreased platelet count, reduced blood potassium, weight loss, increased blood creatinine, decreased white blood cell count, hypersensitivity, allergic reactions, headache, keratitis, pulmonary edema, nausea, diarrhea, tongue swelling, itching, Stevens-Johnson syndrome, toxic epidermal necrolysis, urinary retention, gynecomastia, lethargy, delirium, paralysis (facial paralysis), affective disorders, drowsiness, confusion, agitation, restlessness, seizures, worsening of convulsions, sleep disorders, gastrointestinal disorders, tinnitus, skin diseases, bloody stools, increased BUN, urinary obstruction

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from air and moisture, at a temperature between 15 to 30 degrees Celsius at room temperature. Proper storage will help maintain the drug's efficacy over time.

Appearance and packaging

Appearance

Hard capsules with a brownish-red upper and white lower part, filled with a white to pale yellow powder.

Package unit

30 capsules/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.